sabarubicin has been researched along with bay 11-7082 in 1 studies
| Studies (sabarubicin) | Trials (sabarubicin) | Recent Studies (post-2010) (sabarubicin) | Studies (bay 11-7082) | Trials (bay 11-7082) | Recent Studies (post-2010) (bay 11-7082) |
|---|---|---|---|---|---|
| 29 | 5 | 4 | 570 | 1 | 383 |
| Protein | Taxonomy | sabarubicin (IC50) | bay 11-7082 (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.82 | |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 2 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 2 | |
| Transcription factor p65 | Homo sapiens (human) | 2.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binaschi, M; Camarda, G; Goso, C; Maggi, CA; Manzini, S; Salvatore, C | 1 |
1 other study(ies) available for sabarubicin and bay 11-7082
| Article | Year |
|---|---|
NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780.
Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Survival; Disaccharides; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Female; Gene Expression; Humans; Multidrug Resistance-Associated Proteins; NF-kappa B; Nitriles; Ovarian Neoplasms; RNA, Messenger; Signal Transduction; Sulfones; Time Factors; Vinblastine | 2005 |